Ultragenyx Pharmaceutical Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
RARE Company Description
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
RARE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view RARE Smart Score
Score Breakdown
RARE Company Description
Show More
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of RARE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RARE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on RARE's company Twitter account
WallStreetBets
Number of mentions of RARE in WallStreetBets Daily Discussion
RARE News
Recent insights relating to RARE
CNBC Recommendations
Recent picks made for RARE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in RARE
Corporate Flights
Flights by private jets registered to RARE
Our Analysis